The CDC's EGAPP initiative: Evaluating the clinical evidence for genetic tests

American Family Physician

Volumn 80, Issue 11, 2009, Pages 1218-

  Berg, Alfred O ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; IRINOTECAN; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN;

BREAST CANCER; COLORECTAL CANCER; DEPRESSION; EDITORIAL; FAMILIAL CANCER; GENE EXPRESSION; GENETIC ANALYSIS; GENOME; GENOTYPE; HUMAN; MEDICAL DECISION MAKING; MEDICAL SOCIETY; MORBIDITY; MORTALITY; NEUTROPENIA; PHYSICIAN; PROGNOSIS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TUMOR GENE; UNITED KINGDOM; UNITED STATES;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); GENETIC TESTING; GENOMICS; HETEROZYGOTE DETECTION; HUMANS; UNITED STATES;

EID: 72049101503     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Editorial

References (7)

1. U.S. Preventive Services Task Force http://www.ahrq.gov/clinic/prevenix. htm. Accessed October 12, 2009.
2. Evaluation of Genomic Applications in Practice and Prevention. http://www.egappreviews.org. Accessed October 12, 2009.
3. Teutsch SM, Bradley LA, Palomaki GE, et al. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet Med. 2009;11(1):3-14.
4. Evaluation of Genomic Applications in Practice and Prevention Working Group. Recommendations from the EGAPP Working Group: testing for cytochrome P450 polymorphisms in adults with nonpsychotic depression treated with selective serotonin reuptake inhibitors. Genet Med. 2007;9(12):819-825.
5. Evaluation of Genomic Applications in Practice and Prevention Working Group. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11(1):35-41.
6. Evaluation of Genomic Applications in Practice and Prevention Working Group. Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer? Genet Med. 2009;11(1):66-73.
7. Evaluation of Genomic Applications in Practice and Prevention Working Group. Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colon cancer treated with irinotecan? Genet Med. 2009;11(1):15-20.